Tactogen Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 12

Tactogen General Information

Description

Operator of a drug discovery and development company intended to make medicines safer, more effective, and more accessible. The company develops empathogen medicines intended to promote mental wellness and openness, and euphoric medicinal compounds produce emotional states, including an optimal balance between openness and motivation that increases the experience of connection between people, enabling healthcare professionals to ensure the development and growth in psychotherapy, decision-making, and psychology, and safer take-home prescriptions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3790 El Camino Real
  • Suite 510
  • Palo Alto, CA 94306
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 3790 El Camino Real
  • Suite 510
  • Palo Alto, CA 94306
  • United States

Tactogen Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tactogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Jul-2026 Completed Clinical Trials - Phase 2
4. Equity Crowdfunding 01-Apr-2023 Completed Clinical Trials - Phase 2
3. Seed Round 26-Jan-2022 Completed Clinical Trials - Phase 2
2. Seed Round 22-May-2021 $1.5M Completed Clinical Trials - Phase 2
1. Early Stage VC 01-Apr-2021 $1.5M $1.5M Completed Clinical Trials - Phase 2
To view Tactogen’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tactogen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug discovery and development company intended to make medicines safer, more effective, and more accessib
Drug Discovery
Palo Alto, CA
4 As of 2026

South San Francisco, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tactogen Competitors (4)

One of Tactogen’s 4 competitors is Mindstate Design Labs, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mindstate Design Labs Venture Capital-Backed South San Francisco, CA
AtaiBeckley Formerly VC-backed New York, NY
Definium Therapeutics Formerly VC-backed New York, NY
COMPASS Pathways Formerly VC-backed Altrincham, United Kingdom
To view Tactogen’s complete competitors history, request access »

Tactogen Patents

Tactogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024303691-A1 New formulations for mental disorders or mental enhancement Pending 15-Jun-2023
EP-4727538-A2 New formulations for mental disorders or mental enhancement Pending 15-Jun-2023
US-20260102372-A1 New formulations for mental disorders or mental enhancement Pending 15-Jun-2023
WO-2024259343-A2 New formulations for mental disorders or mental enhancement Inactive 15-Jun-2023
WO-2024259343-A3 New formulations for mental disorders or mental enhancement Inactive 15-Jun-2023 A61K31/36
To view Tactogen’s complete patent history, request access »

Tactogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tactogen Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ride Home Fund Venture Capital Minority
Angel (individual) Minority
10X Capital Venture Capital Minority
Gaingels Venture Capital Minority
JLS Fund Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Tactogen FAQs

  • When was Tactogen founded?

    Tactogen was founded in 2019.

  • Where is Tactogen headquartered?

    Tactogen is headquartered in Palo Alto, CA.

  • What is the size of Tactogen?

    Tactogen has 4 total employees.

  • What industry is Tactogen in?

    Tactogen’s primary industry is Drug Discovery.

  • Is Tactogen a private or public company?

    Tactogen is a Private company.

  • What is Tactogen’s current revenue?

    The current revenue for Tactogen is .

  • How much funding has Tactogen raised over time?

    Tactogen has raised $1.59M.

  • Who are Tactogen’s investors?

    Ride Home Fund, , 10X Capital, Gaingels, and JLS Fund are 5 of 12 investors who have invested in Tactogen.

  • Who are Tactogen’s competitors?

    Mindstate Design Labs, AtaiBeckley, Definium Therapeutics, and COMPASS Pathways are competitors of Tactogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process